No insider purchase over the last 90 days. The latest, by Shortall Alan, was filed 14 Feb 2012.
Every trade that managers of Unilife Corp disclose to SEC (Form 4) is tracked on this page. No insider at Unilife Corp has published a filing in the past twelve months. The most recent one dates from 30 January 2017.
Looking back to 2010, when coverage begins, insiders filed 26 purchases and 13 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended June 2016 · cache
25 of 120 declarations
Unilife Corp is a company focused on developing drug delivery systems. It emphasizes innovation in the medical device sector.